Update on pertussis and pertussis immunization

Korean Journal of Pediatrics

Volumn 53, Issue 5, 2010, Pages 629-633

  Hong, Jung Yun ^a  

^a Jeju National University School of Medicine   (South Korea)

Author keywords

Outbreak; Pertussis; Vaccination

Indexed keywords

EID: 79951708456     PISSN: 17381061     EISSN: 20927258     Source Type: Journal    
DOI: 10.3345/kjp.2010.53.5.629     Document Type: Review

References (25)

1. Department of Vaccines and Biologicals, World Health Organization. WHO-recommended standards for surveillance of selected vaccinepreventable diseases. Geneva: WHO, 2003: p28.
2. Edwards KM. Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J 2005;24(6 Suppl):104 S -108S.
3. Division of Tuberculosis and Bacterial Respiratory Infections: Korea National Health Institute. The report of a survey for pertussis infection status in Korea. Seoul: Korea National Health Institute, 2007:95-110.
4. Division of Tuberculosis and Bacterial Respiratory Infections: Korea National Health Institute. Serotypic variations of Bordetella pertussis isolated in Korea. Seoul: Korea National Health Institute, 2008:621-25
5. Division of Tuberculosis and Bacterial Respiratory Infections: Korea National Health Institute. Increasing incidence of pertussis in Korea. Seoul: Korea National Health Institute, 2009:709
6. Heininger M, Stehr K, Schmitt-Grohe S. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J 1994;13:306-09.
7. Hewlett EL: A commentary on the pathogenesis of pertussis. Clin Infect Dis 1999;28(2 Suppl):94S-98S.
8. Long SS, Welkon CJ, Clark JL. Widespread silent transmission of pertussis in families:antibody correlates of infection and symptomatology. J Infect Dis 1990;161:480-6.
9. Paddock CD, Sanden GN, Cherry JD, Gal AA, Langston C, Tatti KM. Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis 2008;47:328-38.
10. Harnden A, Grant C, Harrison T, Perera R, Brueggemann AB, White RM, et al. Whooping cough in school age children with persistent cough: prospective cohort study in primary care. BMJ 2006;333:174-7.
11. Ntezayabo B, De Serres G, Duval B. Pertussis resurgence in Canada largely caused by a cohort effect. Pediatr Infect Dis J 2003;22:22-7.
12. Halasa NB, Barr FE, Johnson JE. Fatal pulmonary hypertension associated with pertussis in infants: does extracorporeal membrane oxygenation have a role? Pediatrics 2003;112:1274-8.
13. Centers for Disease Control and Prevention. Pertussis deaths - United States, 2000. MMWR 2002;51:616-8.
14. Cantor RM, Pipas L, McCabe JB. Emergency department evaluation of etiology of pediatric cardiac arrest: the role of postmortem cultures. Pediatr Emerg Med 1990;6:221.
15. U, Kleemann WJ, Cherry JD. For the sudden infant death syndrome study group: A controlled study of the relationship between Bordetella pertussis infections and sudden unexpected deaths among German infants. Pediatrics 2004;114:e9-e15.
16. Bisgard KM, Pascual FB, Ehresmann KR, Miller CA, Cianfrini C, Jennings CE, et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004;23:985-90.
17. Mikelova LK, Halperin SA, Scheifele D. Members of the Immunization Monitoring program, Active (IMPACT). Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada. J Pediatr 2003;143:576-81.
18. Srugo I, Benilevi D, Madeb R. Pertussis infection in fully vaccinated children in day-care centers, Israel. Emerg Infect Dis 2000;6:526-9.
19. Hallander HO. Microbiological and serological diagnosis serological diagnosis of pertussis. Clin Infect Dis 1999;28(2 Suppl):99S-106S.
20. Baughman AL, Bisgard KM, Edwards KM. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin Diagn Lab Immunol 2004;11:1045-53.
21. Bergquist SO, Bernander S, Dahnsjo H. Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects. Pediatr Infect Dis J 1987;6:458-61.
22. von König CH. Use of antibiotics in the prevention and treatment of pertussis. Pediatr Infect Dis J 2005; 24(5 Suppl):66S-68S.
23. Mooi FR, van Loo IHM, van Gent M, Qiushui HE, Bart MJ, Heuvelman KJ. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis. 2009;15:1206-12.
24. de Melker Hester E, Schellekens JFP, Neppelenbroek SE, Mooi FR, Rümke HC, Conyn-van Spaendonck MAE. Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis 2000;6:348-57.
25. Rendi-Wagnera P, Tobiasb J, Moermanc L, Gorena S, Bassald R, Greend M, et al. The seroepidemiology of Bordetella pertussis in Israel - Estimate of incidence of infection. Vaccine 2010;28:3285-90.